Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $103.9900 (-2.69%) ($103.5200 - $107.3300) on Mon. Dec. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.44% (three month average) | RSI | 47 | Latest Price | $103.9900(-2.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.22% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.22% (StdDev 2.44%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
1 - 5 Day Possible Target | $104.21(0.21%) | Resistance Level | $107.03 | 5 Day Moving Average | $106.39(-2.26%) | 10 Day Moving Average | $106.89(-2.71%) | 20 Day Moving Average | $107.03(-2.84%) | To recent high | -8.5% | To recent low | 7.3% | Market Cap | $1.671b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |